drugset / Trial / NCT03493841
Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis
RandomizedCrossoverQuadruple-blindTreatment
Summary
This is a three-week crossover study that will compare how the body absorbs and tolerates two different forms of lipoic acid: R form and racemic form.
Timeline
- Start
- 2018-06-08
- Primary completion
- 2019-01-25
- Completion
- 2019-01-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | alpha-lipoic acid | Small molecule | 600 mg | Oral |
| Subject | alpha-lipoic acid | Small molecule | 1200 mg | Oral |